Literature DB >> 3350594

Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program.

J D Curb1, K Schneider, J O Taylor, M Maxwell, N Shulman.   

Abstract

The 5485 participants in the Hypertension Detection and Follow-up Program, Stepped-Care group form one of the largest groups to date on which detailed surveillance of long-term antihypertensive therapy and drug side effects has been reported. During a 5-year period, among all hypertensive persons (mild, moderate, and severe combined) who were not taking antihypertensive medications at the beginning of the study and who attended the clinic at least once during the 5-year trial, a total of 9.3% had definite or probable side effects severe enough to cause discontinuation of the drug treatment in question. Less than 1% of active participants required hospitalization for side effects. No death that could be attributed to side effects was detected. Thus, the Hypertension Detection and Follow-up Program data, which have previously demonstrated the beneficial effects of antihypertensive therapy, confirm the relative safety of such therapy.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3350594     DOI: 10.1161/01.hyp.11.3_pt_2.ii51

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

Review 1.  The sleep-deprived human brain.

Authors:  Adam J Krause; Eti Ben Simon; Bryce A Mander; Stephanie M Greer; Jared M Saletin; Andrea N Goldstein-Piekarski; Matthew P Walker
Journal:  Nat Rev Neurosci       Date:  2017-05-18       Impact factor: 34.870

Review 2.  The effect of antihypertensive treatment on the quality of later years.

Authors:  M A James; J F Potter
Journal:  Drugs Aging       Date:  1993 Jan-Feb       Impact factor: 3.923

3.  Reserpine: A New Consideration of and Old Drug for Refractory Hypertension.

Authors:  Matthew R Weir
Journal:  Am J Hypertens       Date:  2020-08-04       Impact factor: 3.080

4.  High fat diet confers vascular hyper-contractility against angiotensin II through upregulation of MLCK and CPI-17.

Authors:  Jee In Kim
Journal:  Korean J Physiol Pharmacol       Date:  2016-12-21       Impact factor: 2.016

Review 5.  Current Findings Regarding Natural Components With Potential Anti-2019-nCoV Activity.

Authors:  Jin Zhou; Jie Huang
Journal:  Front Cell Dev Biol       Date:  2020-07-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.